The clinical nutrition market size stood at USD 37.8 billion in 2021, which is expected to reach USD 70.8 billion by 2030, advancing at a CAGR of 7.2% during 2021–2030, as per P&S Intelligence.
The geriatric population across the globe has been registering significant growth since the past few years. As the medical industry has made various advancements when it comes to more effective medication and medical instruments. Owing to this, the life expectancy of people has risen. However, the human body is bound to become weak as it grows old, due to which, older people fall sick more often than adults. This is why, geriatric population needs enhanced medical care frequently.
The digestive system of old people becomes inefficient, making it hard for the body to extract the essential nutrients from the food that is consumed. In addition to this, the loss of appetite is a common problem among older people, which can further result in deficiency of nutrients. Ascribed to these factors, the demand for clinical nutrition has been increasing at a rapid pace. Clinical nutrition helps aged people to meet the needed nutrition intake.
Other than this, the demand for enteral nutrition is also on a rise across the globe, owing to the rising prevalence of central nervous system diseases (CNS) and increasing number of cancer cases. Enteral nutritional supplements are utilized during the treatment of CNS and cancer disorders, since they ensure that patients consume all essential nutrients. Cancer results in decreased appetite, which can further lead to malnutrition. Attributed to this, enteral nutrition is consumed by cancer patients for staying relatively healthy.
Geographically, the Asia-Pacific region is expected to emerge as the largest clinical nutrition market in the coming years, owing to the increasing aging population and surging birth rate. In addition to this, malnutrition is highly prevalent in the region, which is also projected to drive the demand for clinical nutrition in the region. The increasing disposable income of people, growing awareness regarding the benefits of clinical nutrition, and rising expenditure in the healthcare in recent years are further expected to lead to the growth of the regional domain.
The APAC market is projected to witness the highest CAGR, of above 9%, in the coming years. This can be credited to the mounting geriatric population, snowballing birth rate, and high malnutrition rates in the region.
Hence, with the rising count of patients, booming geriatric population, and high count of prematurely born babies, the demand for clinical nutrition products continues to increase.
